Werewolf Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:HOWL) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -42.88 M-40.6 M-32.61 M-56.19 M-60.29 M -51.94 M Cash from investing activities -498 K-3.61 M-769 K-254 K0 — Cash from financing activities 109.43 M15.91 M58.43 M13.08 M6.03 M — Free cash flow -42.88 M-40.6 M-32.61 M-56.19 M-60.29 M -51.94 M

News

Truist sees positive reaction for biotech stocks after FDA official exit

Werewolf Therapeutics explores sale and strategic alternatives

Werewolf Therapeutics stock falls after announcing 64% workforce reduction

Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency

Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock

Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882

H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update

Werewolf reports 30% response rate for WTX-124 in melanoma patients

Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know

MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k

Werewolf Therapeutics (HOWL) former 10% owners sell $183k in stock